The Mexican Ministry of Health has granted marketing authorisation to sanofi-aventis's rimonabant [Acomplia] for use in obese or overweight patients

Source: Inpharma, Volume 1, Number 1564, 2006-11-18 , pp. 23-23(1)

Publisher: Adis International

Keywords: Development-status; Obesity, treatment; Product-approvals; Rimonabant, therapeutic use

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers